The landscape of drug therapy is experiencing a major shift, demanding a re-evaluation of existing strategies. Conventional approaches are being scrutinized by novel research, focusing on individualized medicine. This revised perspective emphasizes specificity in targeting diseases, considering patient biology and lifestyle. More research into sign